NASDAQ:QDEL - Quidel Stock Price, News & Analysis

Quidel trades on the NASDAQ under the ticker symbol "QDEL."

Quidel Co. (NASDAQ:QDEL) announced its quarterly earnings results on Thursday, August, 8th. The company reported $0.36 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.34 by $0.02. The company had revenue of $108.25 million for the quarter, compared to analysts' expectations of $108.40 million. Quidel had a net margin of 13.71% and a return on equity of 23.34%. Quidel's revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.36 EPS. View Quidel's Earnings History.

Quidel is scheduled to release their next quarterly earnings announcement on Tuesday, November 5th 2019. View Earnings Estimates for Quidel.

4 brokers have issued 1-year target prices for Quidel's stock. Their predictions range from $70.00 to $77.00. On average, they anticipate Quidel's stock price to reach $74.00 in the next year. This suggests a possible upside of 14.0% from the stock's current price. View Analyst Price Targets for Quidel.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Quidel in the last year. There are currently 3 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Quidel.

News headlines about QDEL stock have trended negative this week, InfoTrie reports. The research group identifies negative and positive media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Quidel earned a media sentiment score of -2.9 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the next few days. View News Stories for Quidel.

Some companies that are related to Quidel include IPSEN S A/S (IPSEY), Neogen (NEOG), Immunomedics (IMMU), Myriad Genetics (MYGN), Lantheus (LNTH), Intellia Therapeutics (NTLA), Quotient (QTNT), Heska (HSKA), Meridian Bioscience (VIVO), Oxford Immunotec Global (OXFD), Palatin Technologies (PTN), Nymox Pharmaceutical (NYMX), Vermillion (VRML), ImmuCell (ICCC) and Celldex Therapeutics (CLDX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Quidel investors own include Netflix (NFLX), Adobe (ADBE), Intel (INTC), NVIDIA (NVDA), Alibaba Group (BABA), Mastercard (MA), Advanced Micro Devices (AMD), Square (SQ), Visa (V) and Cisco Systems (CSCO).

Quidel's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Price T Rowe Associates Inc. MD (15.74%), Brown Capital Management LLC (14.18%), Vanguard Group Inc. (8.67%), BlackRock Inc. (5.94%), Oracle Investment Management Inc. (4.31%) and Eagle Asset Management Inc. (1.60%). Company insiders that own Quidel stock include Charles P Slacik, Douglas C Bryant, Edward Keith Russell, Jack W Schuler, Karen Gibson, Kenneth F Buechler, Mary Lake Ph D Polan, Michael Donald Jr Abney, Randall J Steward, Ratan S Borkar, Robert Joseph Bujarski, Thomas D Brown and Werner Kroll. View Institutional Ownership Trends for Quidel.

QDEL stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Renaissance Technologies LLC, Price T Rowe Associates Inc. MD, Oracle Investment Management Inc., D. E. Shaw & Co. Inc., Mackenzie Financial Corp, Mackenzie Financial Corp and SG Americas Securities LLC. Company insiders that have sold Quidel company stock in the last year include Charles P Slacik, Douglas C Bryant, Edward Keith Russell, Karen Gibson, Kenneth F Buechler, Mary Lake Ph D Polan, Michael Donald Jr Abney, Randall J Steward, Ratan S Borkar, Robert Joseph Bujarski and Thomas D Brown. View Insider Buying and Selling for Quidel.

QDEL stock was bought by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Invesco Ltd., Brown Capital Management LLC, Nuveen Asset Management LLC, BlackRock Inc., Marshall Wace North America L.P., Man Group plc and Chicago Equity Partners LLC. View Insider Buying and Selling for Quidel.

Shares of QDEL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of QDEL stock can currently be purchased for approximately $64.90.

Quidel has a market capitalization of $2.69 billion and generates $522.28 million in revenue each year. The company earns $74.18 million in net income (profit) each year or $2.82 on an earnings per share basis. Quidel employs 1,224 workers across the globe.View Additional Information About Quidel.

The official website for Quidel is http://www.quidel.com/.

Quidel's mailing address is 12544 HIGH BLUFF DRIVE SUITE 200, SAN DIEGO CA, 92130. The company can be reached via phone at 858-552-1100 or via email at [email protected]